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Introduction {#sec001}
============

Newcastle Disease (ND) is a viral disease spread worldwide of birds caused by virulent strains of the Newcastle Disease virus (NDV). The virus belongs to the genus *Avulavirus*, family *Paramyxoviridae*, order *Mononegavirales* \[[@pone.0238068.ref001]\]. It is classified as avian paramyxovirus type 1 (APMV-1). AMPV-1 has a negative-sensed, single stranded, filamentous RNA genome and a glycoprotein and lipid membrane. Different strains of AMPV-1 are classified according to their Intracerebral Pathogenicity Index (ICPI) as apathogenic (ICPI = 0.0), lentogenic (ICPI \< 0.7), mesogenic (ICPI 0.7--1.5) or velogenic (ICPI \> 1.5). Only mesogenic or velogenic strains induce Newcastle Disease \[[@pone.0238068.ref002]\]. AMPV-1 is commonly spread by indirect or direct contact with infected birds. Possible sources of Newcastle Disease infections are poultry, pigeons and free-ranging birds \[[@pone.0238068.ref003]\].

Depending on the Newcastle Disease viral strain and the susceptibility of the host, the virus has a morbidity and mortality of up to 100% \[[@pone.0238068.ref004]\]. Furthermore, the performance of infected flocks decreases significantly and the eggs of infected animals become thin-shelled. Fowl infected with lentogenic strains of the virus usually show only mild respiratory symptoms, however, infections with velogenic strains lead to a catarrhous inflammation of the mucous membrane and central nervous symptoms such as torticollis and opisthotonos \[[@pone.0238068.ref004]--[@pone.0238068.ref006]\].

In the last two years there have been multiple Newcastle Disease outbreaks in Belgium, Switzerland, Sweden and Slovakia \[[@pone.0238068.ref007]\]. The recent outbreaks in Europe usually originated from backyard poultry which then infected commercial poultry flocks \[[@pone.0238068.ref003]\]. An outbreak in poultry with Newcastle Disease virus affects a country's economy substantially, in particular, since countries with a Newcastle Disease outbreak face restricted trading conditions \[[@pone.0238068.ref008]\]. In most countries poultry are vaccinated against ND to prevent outbreaks. However, there are also countries such as Switzerland, Ireland, Norway or Sweden in which a vaccination against Newcastle Disease is strictly prohibited \[[@pone.0238068.ref009],[@pone.0238068.ref010]\]. Vaccination strategies are usually used in countries in which virulent Newcastle Disease virus strains are endemic or infections with low virulent field strains may have significant economic consequences. The reservoir of mildly virulent field strains are free-ranging birds such as wild pigeons (Columbidae) or water fowl such as ducks (Anatidae) or geese (Anserinae) \[[@pone.0238068.ref011]--[@pone.0238068.ref014]\].

In Germany, Newcastle Disease is a notifiable disease. Control and prevention are described in the 'Geflügelpest-Verordnung' (2005) which is based on the European directive EWG RL 92/40. If an infection in poultry is detected, every flock within a radius of 1 km will be culled and every flock within a radius of 3 km has to be tested for Newcastle Disease \[[@pone.0238068.ref015]\]. Furthermore, every single chicken and turkey in Germany has to be vaccinated to build up an immunity against the virus \[[@pone.0238068.ref015]\]. Commonly vaccines with lentogenic APMV-1 strains, like Hitchner B1 or LaSota, as well as apathogenic strains, such as Ulster or VG/GA, are used to vaccinate poultry \[[@pone.0238068.ref016]\]. The vaccination can be performed by veterinarians or trained commercial farmers and since the last amendment of the Animal Vaccination Law as of 31 March 2020 also by trained backyard poultry keepers \[[@pone.0238068.ref017]\]. The vaccination against ND by commercial or non-commercial poultry keepers has to fulfil very strict requirements. The veterinarian supplying the vaccine to the poultry keepers has to request a special permit for the vaccination before the first use and must renew the permit every year. The responsible veterinarian also has to train the breeder with regard to the vaccination technique, verification of the vaccination and side effects of the vaccination. In addition to that, the veterinarian has to check the vaccination success and the flocks have to be supervised regularly, at least every three months \[[@pone.0238068.ref018]\]. Due to these time-consuming administrative efforts it is hardly worthwhile for the typical small-animal veterinarians to supply backyard poultry keepers with ND-vaccines. Instead, it is more likely that small-animal veterinarians will continue to vaccinate backyard poultry flocks themselves, which is, however, more expensive for the backyard poultry breeder. Due to the high costs, there is the risk that backyard poultry breeders do not have their poultry proberly vaccinated. At the same time, there is a rising tendency of keeping small numbers of backyard poultry to produce meat and eggs for self-sufficiency or to "save" layers from slaughter often without knowledge of the applicable laws.

It is common practice in Germany to vaccinate backyard poultry with live attenuated vaccines via drinking water, as it is easier and cheaper than using inactivated vaccines that have to be applied intramuscularly. While there are inactivated vaccines, which maintain immunity for at least eight to twelve months, the manufacturers of all currently available live attenuated Newcastle Disease vaccines in Germany state a duration of immunity of only six weeks. In contrast, in former specifications of product characteristics the revaccination scheme proposed was based on antibody-titer to be controlled by the veterinarian via hemagglutination-inhibition (HI) testing. Based on experiences in the field, it has become common practice to vaccinate poultry only every twelve weeks against Newcastle-Disease \[[@pone.0238068.ref019]\]. Other studies have shown that revaccinated chickens exhibited protection against ND until 55 weeks of age. These chickens were vaccinated with a live-vaccine through eye-drop once and were revaccinated with a live-vaccine intramuscularly for a second time at the age of 32 or 39 days, respectively \[[@pone.0238068.ref020]\].

The use of live vaccines induces cell-mediated immunity as well as humoral immunity \[[@pone.0238068.ref021]\]. Cell-mediated immunity alone is not sufficient by itself to protect chickens against ND, because ND-protection is mainly based on local and systemic antibodies \[[@pone.0238068.ref022]\]. The number of systemic antibodies depends on the invasiveness of the ND-vaccine strain, i.e. the more invasive the strain, the higher the antibody response. Systemic antibodies can be measured easily and cost efficiently via serology \[[@pone.0238068.ref021]\]. Thus, it is the most common way to analyze immunity against a virus in a field study. The predominant systemic antibody in chicken blood is IgY, with a serum concentration of 5--10 mg/ml. In addition to IgY, there are also IgM-antibodies (1--2 mg/ml) and IgA-antibodies (around 3 mg/ml) in the serum. IgM-antibodies are the antibodies that are produced following contact with a pathogen. IgA-antibodies are the most important antibodies in mucosal immunity and can be measured via tracheal flushing or tear collection from living animals \[[@pone.0238068.ref004]\]. The administration of lentogenic ND-live vaccines, such as LaSota or its clone Clone 30, provide local mucosal immunity as well as systemic immunity \[[@pone.0238068.ref023]\]. Therefore, in this study we chose to analyze the systemic immune response of the tested chickens to the vaccination in terms of IgY-antibodies via blood sampling as the most common testing method for vaccination response in the field \[[@pone.0238068.ref004]\].

While the common practice of vaccinating backyard poultry chickens every 12 weeks against ND had mostly found acceptance, the Standing Veterinary Committee on Immunization published an announcement on ND-vaccination of backyard poultry that now requires a revaccination every six weeks when using live vaccines \[[@pone.0238068.ref024]\]. If backyard poultry breeders are forced to vaccinate their animals every six weeks instead of every twelve weeks, there is the risk that backyard poultry will not be vaccinated regularly due to the higher costs and loss of compliance. As a result, the number of immune poultry flocks could significantly decrease and the risk of an outbreak of Newcastle Disease could rise. The aim of our study was to generate field data and evaluate whether the previous vaccination scheme of ND revaccinations every twelve weeks is sufficient or needs to be reconsidered.

Material and methods {#sec002}
====================

In this study chicken (*Gallus gallus* f. *domestica*) from 27 flocks of backyard poultry breeders in Hesse, Germany were tested. The last vaccination had to have been administered at least 60 days before sampling. Of each flock 30 random blood samples were taken as recommended by Siegmann and Neumann \[[@pone.0238068.ref025]\]. Usually between 20 and 30 samples are taken as vaccination monitoring \[[@pone.0238068.ref025]\]. Serology is commonly used to test ND vaccination success in poultry flocks since it is a fast and cost-effective method \[[@pone.0238068.ref004],[@pone.0238068.ref006],[@pone.0238068.ref026]\]. Furthermore, data of all sampled individual chickens such as age (months of life), sex, date of the last vaccination against Newcastle Disease and total number of vaccinations against Newcastle Disease during lifetime were collected. Selection criteria were solely vaccinations with Nobilis ND Clone 30 (MSD, Munich, Germany) (ND live vaccine) which contains a clone of an ND La Sota strain, or Nobilis Ma 5 + Clone 30 (MSD, Munich, Germany) (IB/ND live vaccine), which also contains a Massachusetts strain of Infectious Bronchitis Virus.

Vaccination interval in backyard poultry {#sec003}
----------------------------------------

All tested flocks were vaccinated every 12 weeks with the aforementioned ND and IB/ND live vaccines. Basic immunization schemes according to OIE \[[@pone.0238068.ref027]\] or producer recommendations \[[@pone.0238068.ref028]\] were not implemented in the tested flocks as the breeders typically belong to local breeding associations that vaccinate at fixed dates. Moreover, some breeders of a breeding association breed their chicks at different times, so they would have to organize individual vaccinations at different times to achieve a proper basic immunization. Different vaccination schemes are shown in [Table 1](#pone.0238068.t001){ref-type="table"}.

10.1371/journal.pone.0238068.t001

###### Different vaccination schemes for chickens[\*](#t001fn001){ref-type="table-fn"}.

![](pone.0238068.t001){#pone.0238068.t001g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Name of organization                                    Basic immunization                                                                                                                                                                                  Immunization in laying period
  ------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------
  **OIE**\                                                1\. doa: Hitchner B1                                                                                                                                                                                not necessary in the first laying period
  **(ND is mild and sporadic)**                                                                                                                                                                                                                               

  18.-21. doa: Hitchner B1 or LaSota                                                                                                                                                                                                                          

  10\. woa: LaSota                                                                                                                                                                                                                                            

  Point of lay: Inactivated oil vaccine                                                                                                                                                                                                                       

  **OIE**\                                                1\. doa: Hitchner B1                                                                                                                                                                                not necessary in the first laying period
  **(ND is severe and widespread)**                                                                                                                                                                                                                           

  18.-21. doa: Hitchner B1 or LaSota                                                                                                                                                                                                                          

  35.-42. doa: LaSota                                                                                                                                                                                                                                         

  10\. woa: LaSota + Inactivated vaccine                                                                                                                                                                                                                      

  Point of lay: LaSota + Inactivated vaccine                                                                                                                                                                                                                  

  **MSD**\                                                3\. woa: ND-live vaccine                                                                                                                                                                            every 12 months with inactivated vaccine or every 6 to 12 weeks with ND-live vaccine.
  **(for backyard poultry in Germany and Austria)**                                                                                                                                                                                                           

  9\. woa: ND-live vaccine                                                                                                                                                                                                                                    

  15\. woa: ND-live vaccine                                                                                                                                                                                                                                   

  from the 16. woa: Inactivated vaccine                                                                                                                                                                                                                       

  **Vaccination scheme recommended by StIKo Vet**         2.-3. woa ND-live vaccine                                                                                                                                                                           every 12 months with inactivated vaccine\
                                                                                                                                                                                                                                                              or every 6 weeks with live vaccines if not vaccinated with inactivated vaccine

  9.-12. woa: ND-live vaccine                                                                                                                                                                                                                                 

  14.-16. woa: Inactivated vaccine                                                                                                                                                                                                                            

  **Vaccination scheme used by breeders in this study**   No differentiation between chicks and adult chickens. No classical basic immunization. All chickens (regardless of age) in a flock are vaccinated every 12 weeks with lentogenic ND-live vaccine.   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* doa = day of age; woa = week of age.

Blood samples {#sec004}
-------------

The blood samples were taken via puncture of the *Vena ulnaris* and collected in 2 ml Microcentrifuge Tubes (Carl Roth GmbH). The samples were cooled for transport, then centrifuged for 3 minutes at 12,000 rpm. The serum was separated from the blood clot and stored at -20°C until use.

Serological tests {#sec005}
-----------------

An Enzyme Linked Immunosorbent Assay (ELISA)- test and a Hemagglutination-inhibition test (HI-test) were used to analyze the sera. The HI test is commonly used to test the success of vaccination because it is relatively cheap whereas the ELISA test is typically used to check for infections because of its high sensitivity \[[@pone.0238068.ref027]\]. Both tests were performed by the MSD R&D Service Lab (Boxmeer, Netherlands).

To acquire the titer of Anti-NDV-antibodies in the tested chicken serum, a commercial NDV-ELISA from BioChek Immunoassays was used according to the manufacturer's guidelines. The cut-off used was \<0.35, i.e. results below this value were scored as negative and non-protective, whereas scores above this cut-off were scored as protective. An HI test was used to examine serum samples for the presence of hemagglutination inhibiting antibodies to Newcastle Disease Virus. Two-fold serial dilutions of the test samples were mixed with an equal volume of NDV antigen. Chicken red blood cells (CRBC) were added and subsequently the dilutions were examined for the presence of complete inhibition of the hemagglutination. According to the OIE, results below log~2~ 4 are considered as non-protective \[[@pone.0238068.ref027]\]. Protection against clinical infection and transmission amongst chickens with NDV is given if at least 85% of a flock has a protective titer of at least log~2~ 4 according to OIE standards \[[@pone.0238068.ref027],[@pone.0238068.ref029]\].

Data collection {#sec006}
---------------

To obtain data on the sampled chickens, the breeders were interviewed using a standardized questionnaire. Data collected were age (month of life), breed and sex of the sampled chickens as well as the last date of vaccination of the flock and total number of vaccinations in the lifetime of each chicken. Vaccine data were confirmed by the veterinarian responsible for vaccinating the flock.

Statistical analysis {#sec007}
--------------------

The statistical evaluations were made using the statistical program packages BMDP/Dynamic, Release 8.1 \[[@pone.0238068.ref030]\] and R \[[@pone.0238068.ref031]\].

To describe and analyze the association between the results of the ELISA and the HI test, a two-dimensional frequency table was built and the number of positive test results were compared with the McNemar test of symmetry. Additionally, the kappa coefficient as a measure of reliability between the methods was computed (all with the program BMDP4F).

To analyze and to quantify the effects of the variables, the impact of vaccine type (VacType), time since the last vaccination (VacDistance), total number of vaccinations (totalVacNo) in their lifetime and breed of the chicken (Breed) (all so-called fixed factors) on the measured titer value of each test system, a partial hierarchical linear mixed effects model (glmm) was fitted to the data using the function lmer from the R library lme4. Due to the high number of different breeds in the flocks, breeds were divided in two classes of to analyze the data: Bantam breeds and normal breeds. The hierarchical ordered random factors were given by the chicken within the flocks. (chicken within flock). In these analyses the following linear model (given in the syntax of the function lmer in the lme4 library of R) was used with the data: $$ND‐titer \sim VacType + VacDistance + log2\left( {totalNoVac} \right) + Breed + \left( 1 \middle| Flock \right)$$ where log2 means the base 2 logarithm, the first four terms of the model equation represent the fixed factors and (1\|Flock) the random effects of the chickens within the flocks. The equation was used for the ELISA and the HI test.

Because the statistical distribution of the number of vaccinations was extremely skewed to the right (ranging from 1 to 37), this variable was logarithmically transformed by log~2~ in the regression analysis. In all glmm analyses negative titer values were omitted.

Results {#sec008}
=======

A total of 810 blood samples were taken for vaccination monitoring from 27 different flocks of backyard poultry breeders with an average flock age of 14 months and a total of 48 different breeds (dwarf and normal breeds of *Gallus gallus* f. *domestica*) of backyard poultry in Hesse, Germany. Seven hundred and ninety-four (794) out of 810 blood samples (98.0%) were analyzed. Sixteen (16) samples could not be analyzed due to insufficient sample size or gelatinization of the sample. The majority of the analyzed samples (696/794 (87.7%)) showed a protective antibody titer against Newcastle Disease based on the ELISA or HI test. The ELISA test showed more positive samples than the HI test (McNemar test: p \< 0.0001; [Table 2](#pone.0238068.t002){ref-type="table"} and [Fig 1](#pone.0238068.g001){ref-type="fig"}). In total, a value of 0.574 for the kappa coefficient of reliability was found (p \< 0.0001).

![Proportion of animals with protective titer in ELISA and HI test.](pone.0238068.g001){#pone.0238068.g001}

10.1371/journal.pone.0238068.t002

###### Results of the ELISA and HI test.

![](pone.0238068.t002){#pone.0238068.t002g}

  ELISA Test     HI Test       Total         
  -------------- ------------- ------------- --------------
  **Negative**   98 (12.3%)    4 (0.5%)      102 (12.8%)
  **Positive**   103 (13.0%)   589 (74.2%)   692 (87.2%)
  **Total**      201 (25.3%)   593 (74.7%)   794 (100.0%)

The evaluation of the questionnaires from the breeders showed that 240/794 chickens (30.2%) from eight breeders were vaccinated with the IB/ND-vaccine, whereas 570/794 chickens (71.8%) from 19 breeders were vaccinated with the ND vaccine. The last vaccination was carried out between 69 and 111 days before sampling, with an average of 83.1 days (± 9.8 days Standard Deviation) following the last vaccination. Chickens were vaccinated between one and up to 37 times in their lifetime in regular intervals of 12 weeks with an average of 3.25 vaccinations and a median of 1 vaccination per chicken. Chickens tested were between five and 139 months old with a median of 14.4 months. One third of the chickens were male and two-thirds female. The tested chickens belonged to 48 different breeds. These were categorized as dwarf (436 chickens of 25 breeds) and normal breeds (374 chickens of 23 breeds) for further investigation.

The mean titer values of all tested flocks were 10.86 in the ELISA test and 4.84 in the HI test ([Table 3](#pone.0238068.t003){ref-type="table"}). The number of animals per flock with a protective titer according to the HI or the ELISA test varied between 10.0% and 100.0% with an average of 88.0%. The results of the ELISA tests exhibited a protective titer (\>85% chickens with protective titer) in 19 of 27 flocks. The results of the HI tests showed a protective titer in 13 of 27 flocks. In flock No. 2 only 10.0% of the chickens showed a seroconversion with a mean titer value of 1.06 in the ELISA test and 0.10 in the HI test. Both test values are considered non-protective. One flock was vaccinated by dissolving the ND vaccine in cold oatmeal and feeding it directly to the chickens, all chickens of this particular flock showed seroconversion and protective antibody titers.

10.1371/journal.pone.0238068.t003

###### Mean titer value of each flock in the ELISA test and HI test and percentage of animals with a protective titer per flock[\*](#t003fn001){ref-type="table-fn"}.

![](pone.0238068.t003){#pone.0238068.t003g}

  Flock No.   Days since last vaccination   ELISA test      HI test        Average age of the tested chickens in months   Percentage of animals per flock with protective titer[\*\*](#t003fn002){ref-type="table-fn"} (ELISA/HI)
  ----------- ----------------------------- --------------- -------------- ---------------------------------------------- ---------------------------------------------------------------------------------------------------------
  **1**       70                            11.00           4.33           6.6                                            90.0 (90.0/85.2)
  **2**       76                            1.06            0.10           5.8                                            10.0 (10.0/0.0)
  **3**       69                            11.27           6.13           20.6                                           100.0 (100.0/96.6)
  **4**       111                           7.96            2.80           5.0                                            70.0 (70.0/43.3)
  **5**       69                            11.27           5.07           9.4                                            93.3 (93.3/73.3)
  **6**       87                            12.24           5.10           6.2                                            100.0 (100.0/90.0)
  **7**       74                            9.19            3.48 (29/30)   6.2                                            76.7 (76.7/58.6)
  **8**       81                            13.51           7.73           16.2                                           100.0 (100.0/100.0)
  **9**       74                            11.19           4.33 (27/30)   7.4                                            100.0 (93.3/88.9)
  **10**      75                            10.99           4.73           5.0                                            93.3 (93.3/83.3)
  **11**      90                            12.39           5.82 (28/30)   13.4                                           100.0 (100.0/93.1)
  **12**      79                            8.15            3.52 (29/30)   13.4                                           66.6 (66.6/51.7)
  **13**      72                            9.55            3.69           9.0                                            80.0 (80.0/56.7)
  **14**      72                            12.36           5.37           13.0                                           97.0 (97.0/80.0)
  **15**      72                            7.57            2.73           7.8                                            63.3 (63.3/46.7)
  **16**      87                            12.35           5.68 (28/30)   10.6                                           100.0 (100.0/92.9)
  **17**      87                            9.50            3.47           5.0                                            86.6 (83.3/63.3)
  **18**      89                            12.86           5.39 (28/30)   21.0                                           100.0 (100.0/92.9)
  **19**      89                            13.76           7.36 (28/30)   30.2                                           100.0 (100.0/96.4)
  **20**      89                            11.36           4.24 (29/30)   14.6                                           93.3 (93.3/69.0)
  **21**      89                            12.06           5.64 (28/30)   10.6                                           93.3 (93.3/89.3)
  **22**      89                            11.61           5.10           7.8                                            93.3 (93.3/83.3)
  **23**      89                            11.58           4.73           6.6                                            96.7 (96.7/80.0)
  **24**      89                            12.71           5.87           28.6                                           100.0 (100.0/93.3)
  **25**      89                            8.78            4.37           13.0                                           73.3 (73.3/63.3)
  **26**      96                            12.94           7.80           31.4                                           100.0 (100.0/100.0)
  **27**      90                            12.22 (28/30)   6.17 (28/30)   53.4                                           100.0 (100.0/100.0)
  **total**   83                            10.86           4.84           14.0                                           88.0 (87.7/76.7)

\* (x/x) = number of samples analyzed.

\*\* = chickens that had protective titers in one of both tests regarded as protected.

The analysis of the titer values for both test systems by means of the partial hierarchical linear mixed effects regression model showed only---yet very clearly---a significant effect of the log~2~ number of vaccinations per chicken (for both tests: p \< 0.0001; [Table 4](#pone.0238068.t004){ref-type="table"}). Neither for time since the last vaccination (distance) nor the vaccine nor the breed could statistically significant effects be shown.

10.1371/journal.pone.0238068.t004

###### Results of linear regression with the partial hierarchical linear mixed effects regression model.

![](pone.0238068.t004){#pone.0238068.t004g}

  ELISA test                                                                                           
  ---------------------------------------------------------------- ---------- --------- -------- ----- ----------
  **(Intercept)**                                                  12.67747   0.73100   17.343   676   \<0.0001
  **Distance**                                                     -0.00966   0.00890   -1.086   676   0.2781
  **log**~**2**~ **NumVac**[\*](#t004fn001){ref-type="table-fn"}   0.46227    0.03068   15.068   676   \<0.0001
  **Vaccine**                                                      0.16749    0.19172   0.874    676   0.3826
  **Breed**                                                        -0.11603   0.10265   -1.130   676   0.2587
  **HI test**                                                                                          
  **(Intercept)**                                                  5.70464    1.52568   3.739    634   0.0002
  **Distance**                                                     -0.01007   0.01858   -0.542   634   0.5880
  **log**~**2**~ **NumVac**[\*](#t004fn001){ref-type="table-fn"}   0.82524    0.05782   14.273   634   \<0.0001
  **Vaccine**                                                      -0.06481   0.40119   -0.162   634   0.8717
  **Breed**                                                        -0.22640   0.19366   -1.169   634   0.2428

\* = log~2~ NumVac = log~2~ Number of vaccinated animals

^\#^ = Standard error of the model coefficient estimate.

For the effect of the log~2~ number of vaccinations, the regression coefficients allow the interpretation that for the ELISA-titer the mean increase amounts to 0.46 for doubling the number of vaccinations where for the HI test the titer increase equals 0.83 in mean when the number of vaccinations is doubled.

Discussion {#sec009}
==========

A total of 810 blood samples from 27 flocks of backyard poultry breeders in Hesse, Germany were taken for this study. Of these samples 794 were able to be evaluated. On average, all flocks showed a protective antibody titer in 88.0% (combined test results) of the animals tested. At the time of the last vaccination, the breeders did not know that a serological check would be performed. Due to the voluntary participation of the backyard poultry breeders, it can be assumed that all of the participating breeders are confident in their vaccination technique. This was verified by the positive ND protection results of this study in 21 of 27 cases, where the critical percentage of animals with a protective titer (combined ELISA- and HI-results) of ≥ 85% according to the OIE was reached \[[@pone.0238068.ref027]\]. To be able to ensure properly performed vaccination, periodic serological controls of the flocks of backyard breeders are recommended. Although all of the samples were taken in Hesse, the results can be transferred to other regions if the vaccination schemes do not differ from the one used in this study (according to [Table 1](#pone.0238068.t001){ref-type="table"}).

All chickens were randomly selected by the breeders giving a cross section of all breeds and ages of the flock. All flocks were clinically healthy. The number of 30 samples taken for vaccination status are the standard number of samples for ND vaccination checks in poultry flocks \[[@pone.0238068.ref025]\]. Germany is currently ND free, and to our knowledge there has never been an outbreak of APMV-1 in these flocks. Hence, all detected ND antibodies can be interpreted as vaccination-induced.

Interestingly, flocks that were young in age (average of 5 months) and only vaccinated once, such as flock number 10 (75 days since vaccination) and flock number 17 (87 days since vaccination), already showed sufficient protection based on the combined test results (93.3%/86.6%). In literature, it has already been shown that a one-time vaccination with the IB/ND vaccine used in this study can induce a moderate antibody titer which can be verified 40 days post vaccination \[[@pone.0238068.ref032]\]. It is very likely that the same effect appears if the monovalent ND vaccine is used \[[@pone.0238068.ref033]\]. The statistical data evaluation showed that the titer of the ND vaccination increased significantly with a doubling of vaccinations. Therefore, it is important to revaccinate chickens properly to booster the immune response until \>85% of chickens of a flock have protective titers. This can be achieved through vaccination schemes that propose a basic immunization of the chicks and pullets (e.g. vaccination schemes in [Table 1](#pone.0238068.t001){ref-type="table"}) and a test of the flocks before the laying period. According to the results of this study it is possible to stretch the vaccination interval with ND live vaccines proposed by the StIKo Vet from six to twelve weeks as most of the tested flocks had protective titers ([Table 3](#pone.0238068.t003){ref-type="table"}).

The short revaccination interval of six weeks given in the vaccines' SPCs are presumably owing to the approval procedures of vaccines, requiring cost and time-intensive challenge studies \[[@pone.0238068.ref017],[@pone.0238068.ref034]\]. Due to animal welfare issues and costs, it appears plausible to keep the duration of any animal experiment as short as possible. The duration of immunity of vaccines in the EU is usually given as a minimum time span \[[@pone.0238068.ref035]\]. Furthermore, the largest market for Newcastle Disease live attenuated vaccines is the conventional broiler market, where flocks are slaughtered between four and six weeks of age \[[@pone.0238068.ref025]\]. In 2017 approx. 677 million broilers were produced in Germany \[[@pone.0238068.ref036]\]. Broilers are usually vaccinated once with live vaccine via drinking water or spray application \[[@pone.0238068.ref005]\]. In comparison to these numbers in Germany there are only approximately 300,000 breeding chicken in the sector of backyard poultry from 35,000 breeders according to the Bund Deutscher Rassegeflügelzüchter (BDRG), the largest backyard poultry association worldwide \[[@pone.0238068.ref037]\]. Due to the aforementioned reasons, there seems to be no commercial need to analyze a potentially longer period of protection, which was shown in this study.

Both test systems, the ELISA and the HI test, were compared in the statistical analysis. The results of both tests were similar, but it was obvious that more samples were positive in the ELISA than in the HI test. It is known that ELISA tests show a higher specificity and sensitivity than HI tests and therefore give more positive results than HI-tests in vaccination checks \[[@pone.0238068.ref038],[@pone.0238068.ref039]\]. This can be explained by the nature of both tests. The HI test only detects the antibodies against the HN spike glycoproteins on the surface, whereas ELISA test are potentially able to detect all antibodies against the NDV as the whole virus is used as antigen \[[@pone.0238068.ref040]\]. In contrast, the ELISA test may detect antibodies which probably do not act as protective antibodies \[[@pone.0238068.ref041]\]. HI tests are widely used to detect the virus after the occurrence of ND, while ELISA tests are commonly used in vaccination trials. Both tests usually correlate at the level of flock rather than that of the individual animals and can be used to check titers after vaccination of poultry flocks \[[@pone.0238068.ref027]\]. In light of the broad range of detection of the ND ELISA, we used the test in addition to the HI test as the current gold standard.

There were no significant differences when comparing the use of combined IB/ND vaccine to the use of the ND vaccine. On the one hand this is not surprising, since both vaccines contain the same ND vaccine strain: ND Clone 30. On the other hand, both viruses in the combined vaccine, the IBV and the NDV, target the same cells. Hence, it could be assumed that a simultaneous infection would affect antibody production. Negative effects on antibody production after a vaccination with mixed monovalent-vaccines against NDV and IBV are well known \[[@pone.0238068.ref042]\], since the IB-Virus vaccination seems to decrease the capacity of the gland of Harder \[[@pone.0238068.ref043]\]. This effect does not seem to occur when the combination of both viruses had been carried out by the manufacturer as in case of the IB/ND vaccine used in this study \[[@pone.0238068.ref033]\]. Interestingly, a study on vaccination against NDV with different vaccines showed that the combined IB/ND vaccine used in this study induces higher antibody production than other combined IB/ND vaccines or an ND vaccine alone after single vaccination. The same study showed that revaccination with a monovalent ND vaccine, the same as used in this study, results in poor antibody titers in comparison to other vaccines \[[@pone.0238068.ref044]\]. These results could not be confirmed by our study.

It is stated in literature that antibody titers against ND can vary in different breeds or sexes, because of differences of the speed of the metabolism or the stress induced by the onset of laying \[[@pone.0238068.ref045]--[@pone.0238068.ref047]\]. In this study we tested many different breeds of backyard poultry (46 breeds) as well as some conventional layer hybrids (2 breeds) and hybrids of unknown origin, but there was no significant impact of either sex or breed on the ND antibody titer.

Seven of the 27 flocks showed no sufficient seroconversion in the flocks according to the combined test results. Based on the results of the ELISA test alone 19 flocks showed sufficient seroconversion, while 12 flocks had sufficient seroconversion solely considering the solely the HI test results. The success of a vaccination is influenced by many different factors. On the one hand, the type of chicken (layer or broiler), genetics and age of the birds are biological factors of the chickens themselves. On the other hand, the success of the vaccination is also affected by the vaccination technique. Important aspects of the vaccination technique are the route of vaccination (eye drop, spray, drinking water), the storage of the vaccine, the number of birds per drinking place, the hygiene of the administering vessel, the quality and temperature of the drinking water used to dissolve the vaccine, and the number of doses of vaccine per bird \[[@pone.0238068.ref048]\]. Common mistakes in vaccinations are poor management with a too long time span between the dissolution and administration of the vaccine, contaminated drinking systems and use of too warm or contaminated water to administer the vaccine. All such mistakes result in a drop of vaccine dose per chicken or even in the administration of completely destroyed virus making the vaccination less or non-effective \[[@pone.0238068.ref049]\]. Underlying immunosuppressive diseases like Gumboro disease, Marek's disease or Chicken Anemia Virus may also contribute to insufficient antibody-titers \[[@pone.0238068.ref004]\]. No clinical symptoms of these diseases or higher losses were observed by the breeders in the tested flocks. The reason for insufficient seroconversion in some flocks remains unclear and requires more investigation.

One breeder administered the vaccine for years only through cold oatmeal. Nevertheless, this breeder\`s flock also showed seroconversion. It has already been shown that some Newcastle Disease vaccination strains could be used to vaccinate chicken via their food such as grain like maize and barley \[[@pone.0238068.ref050],[@pone.0238068.ref051]\]. This has not been reported with the ND Clone 30 strain of ND LaSota yet. Furthermore, it is known that oats contain saponins which can influence the production of Newcastle Disease antibodies positively \[[@pone.0238068.ref052],[@pone.0238068.ref053]\].

In this study, we showed that a sufficient Newcastle Disease titer (\>85% according to the OIE) was able to be verified in 20 of 27 backyard poultry flocks with a vaccination interval of twelve weeks. A protective titer which shields the flocks against mortality from Newcastle Disease is highly plausible since another study showed reduced signs of infection and a protection against mortality with higher titers then log~2~ 2 \[[@pone.0238068.ref029]\]. The mean number of animals per flock with a protective titer is 88.0% ([Table 3](#pone.0238068.t003){ref-type="table"}), which is sufficient following the minimum requirement of 85% \[[@pone.0238068.ref027],[@pone.0238068.ref029]\]. Therefore, we assume that a vaccination interval of twelve weeks can be upheld without sacrificing protection against a Newcastle Disease-outbreak if the flocks are regularly tested and already show a protective titer \>85%.

Conclusion and recommendations {#sec010}
==============================

This study showed that a vaccination program against Newcastle Disease with a revaccination interval of twelve weeks provides protection against ND for backyard poultry using the Nobilis ND Clone 30 vaccine (MSD, Munich, Germany) or the Nobilis IB Ma5 + ND Clone 30 vaccine (MSD, Munich, Germany) in the flocks studied in Hesse, Germany. The low seroconversion of some flocks emphasizes that flocks have to be tested regularly to detect vaccination failures that can be caused by many factors. The administration of vaccines with the ND Clone 30 strain (MSD, Munich, Germany) through food was sufficient to induce a protective antibody titer in one flock, however further investigations are needed in this regard.

Supporting information {#sec011}
======================
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(XLSX)

###### 

Click here for additional data file.

###### Statistical analysis.

(ZIP)

###### 

Click here for additional data file.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

Reviewer \#3: Yes

Reviewer \#4: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Overall, there is a lot of value to this manuscript in determining NDV antibody titers after vaccination in backyard flocks for prolonged periods (69 -- 111 days), as understanding titer levels for longer durations is critical to understanding protection for backyard flocks versus commercial flocks. Backyard flocks can be major reservoirs for many different poultry diseases in numerous countries if not vaccinated and maintained correctly, thus understanding these parameters to help in defining the most accurate recommendations for backyard breeders is vital to global poultry health. However, the major issue with this manuscript is the discussion section, as there are numerous problems including confusing statements and drawing conclusions not supported by the results of the study. The discussion section should be completely rewritten to better discuss the specific results of the study, and what they mean to the bigger picture including the current literature. Additionally, the manuscript overall needs to be polished up and the writing cleaned up to make the general message clearer to the reader and easier to understand in general. There are many grammatical errors and typos throughout the manuscript that should be corrected by the authors.

Specific comments:

Abstract

Line 27 -- 32 -- It is unclear to the initial reader is the purpose to compare 6 weeks recommended by the Standing Committee or SPCs at 12 weeks. Later it becomes clear that SPCs also recommend the 6 weeks, but the standard practice in Germany is 12 weeks. Therefore, these two sentences should be re-worked to clarify the meaning.

Introduction

Line 47 -- 51 -- Order of these sentences flows very weird and is a little confusing to the reader.

Line 52 -- 59 -- General paragraph feels like just random facts put together. Might be worth defining velogenic, mesogenic, lentogenic, and asymptomatic enteric strains a little better. Additionally, might be worth mentioning that lentogenic viral strains are commonly used for vaccines.

Line 62 -- Beginning of sentence does not flow with previous sentence, confusing

Line 63 -- poultry infection should be changed to poultry outbreak

Line 66 -- poultry is vaccinated to poultry are vaccinated

Line 80 -- 84 -- Run-on sentence, should be broken up

Line 100 -- 102 -- Cell mediated immunity is the immune response that does not involve antibodies. Plus, mucosal immunity would suggest IgA response, should be mentioned how serum levels of IgY correspond to IgA levels for protection. This sentence is a little confusing and should be clarified

Materials and Methods

Line 120 -- Hesse, Germany

Line 130 -- 134 -- How close is the blood collection method to that commonly used for antibody titer checks in flocks? This should be mentioned and/or referenced.

Line 138 -- control changed to test

Line 139 -- ELISA-tet to ELISA-test

Line 142 -- chickenserum to chicken serum

Line 146 -- An HI-Test to A HI-Test

Line 155 -- Line 157 -- confusing is this saying flock immunity can vary or % protective titer of the flock, needs clarification

Results

Table 2 -- Might be worth including breeds within the flocks and/or average age of flocks in this table

Table 2 -- correct the switch between commas and decimal points in the numbers

Line 218 -- There is no table 4 as cited in the paper

Line 216 -- 220 -- This section should be re-worked and cleaned up for clarity and grammatical errors

Discussion

Since the \# of vaccines had the biggest statistical impact on the antibody titers would this not argue for more frequent vaccinations, thus every 6 weeks instead of 12 weeks. However, this is not discussed in the discussion, and the major statistical factor determined in the study is not even really mentioned in the discussion of the paper. This should be addressed

Line 233 -- Hesse, Germany

Line 234 -- 241 -- The authors keep switching between the 58% and the OIE recommended 85% for flock immunity when it seems to fit their discussion better. What does the German Veterinarian Standing Committee consider the %? Would be better throughout the paper to stick with one percentage that has been justified and is used in Germany.

Line 242 -- 244 -- Seems unlikely that the authors are going to find a region with the exact same vaccines, vaccination intervals, breeds, and climatic parameters for this to perfectly match as stated in the sentence. Additionally, the results of the paper indicate that there is no statistical impact due to vaccine type, last vaccine intervals or breeds therefore the authors are arguing against the authors' own results. Need to comment on the author's own results and the impact beyond Hesse, Germany.

Line 245 -- chicken to chickens

Line 247 -- 30 samples taken for the vaccination control were determined statistically? There is no mention in the methods about running statistics to determine the 30 samples

Line 251 -- 252 -- No data is present in the paper to support this statement, there was only one time point taken from the chickens therefore the authors cannot compare between flocks to say there is no decrease in titers between 69 and 111 days after vaccination. The authors would need to study the flocks at different time points to determine that within each flock there was not a drop across those time periods, because it is possible that the flocks at 111 days had an extremely high titer at 69 days that has dropped down by 111 days.

Line 254 -- are dropping to drop

Line 257 -- to literature change to the literature

Line 259 -- 261 -- statement of doubling the vaccination would again argue in favor of every 6 weeks instead of 12 weeks, which would double the vaccination

Line 278 -- 281 -- I understand the reason for the information, but these comments seem to just be dropped into the end of the paragraph and do not flow with the rest of the paragraph.

Line 282 -- 284 -- This sentence contradicts itself, if they are congruent then they are the same. Additionally, the kappa coefficient of reliability was 0.574 that could be argued to around the middle ground, so this should be discussed more in the discussion and the impact ELISA versus HI-Test could have on predicting flock immunity. The authors need to discuss their own results and the meaning.

Line 296 -- 298 -- unclear sentence

Line 298 -- 303 -- Unclear as to the point of this section and how it fits into the results of the study, particularly as the results show no statistical difference in type of vaccine

Line 306 -- 314 -- How does this section relate to the breeds in this study? This section seems to go off on a tangent to just fill space, discuss the results of the paper

Line 327 -- 329 -- No evidence this is what happened, particularly as the authors just mentioned numerous other factors that could impact the antibody titer in a flock. Was this flock older? Or younger? Different breed compared to all the others? Additionally, the authors present no data to suggest there was any issues with vaccination technique.

Line 332 -- 333 -- Sentence needs to be fixed

Line 339 -- 341 -- sentence is confusing OIE was 85% whereas again using 58% to justify the discussion. Need to justify one percentage and use it throughout the manuscript particularly the discussion.

Line 344 -- 346 -- Confusing sentence, needs fixing

Conclusion

Line 354 -- 356 -- Again, the authors do not present any data to be able to draw this conclusion on the handling of the vaccine. Either data needs to be added to the manuscript to justify the statement or remove the statement.

Reviewer \#2: 1. The meaning of this report on the evaluate if a vaccination interval of twelve weeks against Newcastle Disease under field conditions results in sufficient seroconversion to protect the flocks is significant, especially in Germany. By the author's work, some useful results gotten, like a vaccination interval of every twelve weeks with the live-vaccines tested is suitable for a vaccination protocol against Newcastle Disease..

2\. Vaccine can cause an enormous change of immunocytes,cytokines and antibody, cause a series of pathological and physiological change in the body.Therefore I suggest the author could discuss deeper about the effection about the vacction protocol by whether NDV infection rate were reduced which can be diagnosed by a number of different laboratory tests.For example,conclusion the change of B cell and T cell can reflected the pathogenesis. It may improve the diagnose. The main support data were only serological testing results I thought not enough.

3\. If the author showed the data by graphs will be better than too many tables.

Reviewer \#3: The manuscript presents relevant data for poultry practitioners and producers in Germany.

I have just a few observations as follows;

Since it has been stated that there is a current directive to vaccinate birds at 6 weeks, what necessitated that decision? Was is based on a study recommendation?

Is the protective antibody observed in this study significantly higher that what was observed following vaccination at 6 weeks?

Some of the flocks used in the study had less than 12 weeks since the last vaccination, would it not be better to give a range in days instead of weeks ?

Again, in order to appreciate the lower and upper limits, it would be preferable to use Mean and SE or SD.

In-text citations are inconsistent e,g lines 248, 270,281, 286, 314, 322\....just to mention a few. Use standard journal citation and referencing style.

Reviewer \#4: \[General comments\]

This paper describes the analytical results on a survey for anti-NDV antibodies to discuss whether twelve-week interval of NDV vaccination is suffice to keep backyard poultry in Germany. The authors concluded that a vaccination interval of twelve weeks with the live-vaccines was suitable for vaccination protocol in backyard poultry.

The authors describes as the reason for this study is the direction from German Veterinarian Standing Committee of Immunization to re-vaccinate for NDV every six weeks, instead of every twelve weeks, which was regularly performed in Germany. However, in OIE manual issued in 2006, it is recommended to vaccinate every 8 weeks to keep HI titer of 2\^5. In this manuscript, the reason for the change to re-vaccination of six-week interval was not clearly described, thus, for the reviewer, the contents of this paper seemed to be of domestic importance.

\[\[Comments for the contents\]\]

\[Sample information\]

Because the samples were taken from backyard chichen, the age, breed, aim and so on, would be variable. However, as the focus of this paper is to demonstrate the comparable efficacy to keep anti-NDV antibody titer by re-vaccination in twelve-week intervals, compared to those in six-week intervals.

In the S1 Raw data sheet, flock number, age in month, number of times of vaccination, and ELISA and HI for titersindividuals are listed. In the text, the period from the last vaccination is described as 69-111days (approx. 10-16 weeks after LAST vaccination). However, I could not understand in which flock or even in which individuals followed six- or twelve-week interval revaccination, if the repeats of vaccination affects to the remaining titer. For example, chickens of 29 weeks old in different flock received 7 vaccinations, while 5 months chickens which are the major age group in this study encompassing 490 chicken out of total 810 chickens (60.5%) received 1 time vaccination. In OIE manual (2006), breeding hens are recommended to vaccinate twice by 14 or 18 weeks of age, for layer and broiler chickens, respectively (ND3.1-16FINAL(29Nov06) appendix 5). So, the more than half of chickens of 5 month received only single vaccination means that their vaccination schedule was different from the regular ones. The detailed schedule of vaccination of backyard chickens should be noticed for better understanding of the situdation.

\[Value in tables\]

From the reference of van Boven et al (2008) demonstrating vaccinated chickens with HI titers of 2\^3 or more with strong protection, setting HI titer of 2\^4 as the minimum protective titer would be acceptable. However, in materials and methods, the authors described that HI titer of 2\^3 or less is considered as negative (according to OIE). I think it is unclear statement because HI titer of 2-1 to 2-3 is still clear in HI titer. OIE manual explained that as a protective titer, they recommended to determine HI titer of 2\^4 or 2\^3.

In table 2, the flock 1 including 30 samples in which includes 3 unmeasulable samples, 3 samples with HI titer of \<1, one of HI titer of 3. That means \"protective\" titer of 2\^4 or more would be 23 out of 27 available sample, equals to 85.2%, which is described as 90% protective. As similar, in flock 2, all of 30 samples showed HI titers of 1 or \<1. So, percentage of protective titer should be 0.0% (0/30), which is described as 10%. In materials and methods, the authors mentioned that they used R software. However, the authors should describe essential calculation formulars in the materials and methods so that the readers can easily understand.

In table 2 \",\" and \".\" are mixed as period. \".\" should be used.

As similar, protective HI titer in table 2 is 89%, while positive HI test (2\^4 or more?) in table 1 is 74.7%. My calculation from supplimented law data for proportion of HI titers 2\^4 or more is 75.3% (593/788: Total 810, IS=22, \<1=122, 1-3=73). No formular or legends (because they are tables) was indicated for the way of calculation.

\[Result interpretation\]

The title of this manuscript implies to demonstrate the decline of HI titer (or additionally ELISA titer for higher sensitivity) is calm (slow) enough to maintains the anti-NDV antibody titers at the protective levels. Results demonstrated high HI titers were still detected after 12 weeks (84 days). As described in the discussion, the factors such as the way of immunization, breeds, and others might affect to the (maintainance of) HI titers, description of the schedule of vaccination in addition to the number of repeated vaccination times would be required, as described above.

\[Correlation between ELISA titer and HI titer\]

Generally, neutralization titers are not always linearly correlated to whole antibody titers. In some our experiences, the protortion of neutralizing titer increased after repeated immunization. I think the protective value should be based on the HI titer not ELISA titer. In this section, more clear explanation about the aim of statistical comparison of these two values in order to evaluate the comparable efficacy of re-vaccination in twelve-week intervals.

\[breeds, ages, flock differences\]

Even no significant differences were demonstrated, the expectation or some examples in references which shows the difference between dofferent categories. Or if the authors put them for evaluation in case there might have some unexpected differences between breeds or others, the authors should not conclude that those differences might affect to the results (lines 315-322).

\[Proofreading and other\]

Some grammatical mistakes and mistypes were found.　Order of the significant digits for the same category of values should be same.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Hao Peng

Reviewer \#3: No

Reviewer \#4: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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We addressed all issues raised by the reviewers as follows:

Review Comments to the Author

Reviewer \#1: Overall, there is a lot of value to this manuscript in determining NDV antibody titers after vaccination in backyard flocks for prolonged periods (69 -- 111 days), as understanding titer levels for longer durations is critical to understanding protection for backyard flocks versus commercial flocks. Backyard flocks can be major reservoirs for many different poultry diseases in numerous countries if not vaccinated and maintained correctly, thus understanding these parameters to help in defining the most accurate recommendations for backyard breeders is vital to global poultry health. However, the major issue with this manuscript is the discussion section, as there are numerous problems including confusing statements and drawing conclusions not supported by the results of the study. The discussion section should be completely rewritten to better discuss the specific results of the study, and what they mean to the bigger picture including the current literature. Additionally, the manuscript overall needs to be polished up and the writing cleaned up to make the general message clearer to the reader and easier to understand in general. There are many grammatical errors and typos throughout the manuscript that should be corrected by the authors.

• The authors thank the reviewer for the comments and suggestions. The authors rewrote the discussion according to the reviewer's suggestions and we had the study proof-read by a native speaker. The authors addressed the comments on a point-to-point basis as follows:

Specific comments:

Abstract

Line 27 -- 32 -- It is unclear to the initial reader is the purpose to compare 6 weeks recommended by the Standing Committee or SPCs at 12 weeks. Later it becomes clear that SPCs also recommend the 6 weeks, but the standard practice in Germany is 12 weeks. Therefore, these two sentences should be re-worked to clarify the meaning.

• We rewrote the sentences, to clarify the meaning.

Introduction

Line 47 -- 51 -- Order of these sentences flows very weird and is a little confusing to the reader.

• We rewrote/reorganized the sentence to get a better flow and clarify information.

Line 52 -- 59 -- General paragraph feels like just random facts put together. Might be worth defining velogenic, mesogenic, lentogenic, and asymptomatic enteric strains a little better. Additionally, might be worth mentioning that lentogenic viral strains are commonly used for vaccines.

• We rewrote the paragraph to provide the facts in a clearer way. We defined the different strains of ND and also mentioned the lentogenic ND strains later on.

Line 62 -- Beginning of sentence does not flow with previous sentence, confusing

• We rewrote the section.

Line 63 -- poultry infection should be changed to poultry outbreak

• This was amended as suggested.

Line 66 -- poultry is vaccinated to poultry are vaccinated

• This was amended as suggested.

Line 80 -- 84 -- Run-on sentence, should be broken up

• This was amended as suggested.

Line 100 -- 102 -- Cell mediated immunity is the immune response that does not involve antibodies. Plus, mucosal immunity would suggest IgA response, should be mentioned how serum levels of IgY correspond to IgA levels for protection. This sentence is a little confusing and should be clarified

• We rewrote the section to clarify the immune response and also included information about the relation of IgY and IgA.

Materials and Methods

Line 120 -- Hesse, Germany

• This was amended as suggested.

Line 130 -- 134 -- How close is the blood collection method to that commonly used for antibody titer checks in flocks? This should be mentioned and/or referenced.

• This is the common method to test antibody titers in flocks. We made this clear in the revised manuscript and referred to literature in this regard.

Line 138 -- control changed to test

• This was amended as suggested.

Line 139 -- ELISA-tet to ELISA-test

• This was amended as suggested.

Line 142 -- chickenserum to chicken serum

• This was amended as suggested.

Line 146 -- An HI-Test to A HI-Test

• This was amended as suggested.

Line 155 -- Line 157 -- confusing is this saying flock immunity can vary or % protective titer of the flock, needs clarification

• We clarified this by sticking to the OIE recommendations throughout the whole manuscript.

Results

Table 2 -- Might be worth including breeds within the flocks and/or average age of flocks in this table

• We included the average age of the flocks in the table. When we tried to include the different breeds, the resulting table was confusing.

Table 2 -- correct the switch between commas and decimal points in the numbers

• This was amended as suggested.

Line 218 -- There is no table 4 as cited in the paper

• We corrected the information regarding the tables and cited them properly in the revised manuscript.

Line 216 -- 220 -- This section should be re-worked and cleaned up for clarity and grammatical errors

• We rewrote the section as suggested.

Discussion

Since the \# of vaccines had the biggest statistical impact on the antibody titers would this not argue for more frequent vaccinations, thus every 6 weeks instead of 12 weeks. However, this is not discussed in the discussion, and the major statistical factor determined in the study is not even really mentioned in the discussion of the paper. This should be addressed

• We tried to address this more clearly in the discussion. In our opinion based on our filed observations a shorter vaccination interval reduces the willingness of the breeders to vaccinate, so the interval of 12 weeks seems to be a good compromise to uphold the "ND-free"-status of Germany.

Line 233 -- Hesse, Germany

• This was amended as suggested.

Line 234 -- 241 -- The authors keep switching between the 58% and the OIE recommended 85% for flock immunity when it seems to fit their discussion better. What does the German Veterinarian Standing Committee consider the %? Would be better throughout the paper to stick with one percentage that has been justified and is used in Germany.

• Now we stick to the recommendations of the OIE (85 %) throughout the whole paper. The StIKo Vet also consider the 85 % of the OIE as standard.

Line 242 -- 244 -- Seems unlikely that the authors are going to find a region with the exact same vaccines, vaccination intervals, breeds, and climatic parameters for this to perfectly match as stated in the sentence. Additionally, the results of the paper indicate that there is no statistical impact due to vaccine type, last vaccine intervals or breeds therefore the authors are arguing against the authors' own results. Need to comment on the author's own results and the impact beyond Hesse, Germany.

• We rewrote the section as the reviewer suggested.

Line 245 -- chicken to chickens

• This was amended as suggested.

Line 247 -- 30 samples taken for the vaccination control were determined statistically? There is no mention in the methods about running statistics to determine the 30 samples

• We rewrote the sentence to clarify this point. The number of samples were based on literature research.

Line 251 -- 252 -- No data is present in the paper to support this statement, there was only one time point taken from the chickens therefore the authors cannot compare between flocks to say there is no decrease in titers between 69 and 111 days after vaccination. The authors would need to study the flocks at different time points to determine that within each flock there was not a drop across those time periods, because it is possible that the flocks at 111 days had an extremely high titer at 69 days that has dropped down by 111 days.

• We removed the statement as suggested by the reviewer.

Line 254 -- are dropping to drop

• This was amended as suggested.

Line 257 -- to literature change to the literature

• This was amended as suggested.

Line 259 -- 261 -- statement of doubling the vaccination would again argue in favor of every 6 weeks instead of 12 weeks, which would double the vaccination

• We rewrote the section to clarify that the interval of twelve weeks could be a compromise to uphold flock immunity and willingness to vaccinate properly.

Line 278 -- 281 -- I understand the reason for the information, but these comments seem to just be dropped into the end of the paragraph and do not flow with the rest of the paragraph.

• We rewrote the section to include the information in a more meaningful way.

Line 282 -- 284 -- This sentence contradicts itself, if they are congruent then they are the same. Additionally, the kappa coefficient of reliability was 0.574 that could be argued to around the middle ground, so this should be discussed more in the discussion and the impact ELISA versus HI-Test could have on predicting flock immunity. The authors need to discuss their own results and the meaning.

• We rewrote the section and tried to clarify the impact of ELISA vs HI test according to flock immunity.

Line 296 -- 298 -- unclear sentence

Line 298 -- 303 -- Unclear as to the point of this section and how it fits into the results of the study, particularly as the results show no statistical difference in type of vaccine

Line 306 -- 314 -- How does this section relate to the breeds in this study? This section seems to go off on a tangent to just fill space, discuss the results of the paper

• We rewrote the section, deleted unnecessary information and sticked to the results of the paper.

Line 327 -- 329 -- No evidence this is what happened, particularly as the authors just mentioned numerous other factors that could impact the antibody titer in a flock. Was this flock older? Or younger? Different breed compared to all the others? Additionally, the authors present no data to suggest there was any issues with vaccination technique.

• To our experience issues with the vaccination technique are the most common problems in vaccination backyard poultry flocks. Since we cannot prove that this was the cause in this case, we removed the statement.

Line 332 -- 333 -- Sentence needs to be fixed

• We rewrote the section and fixed all sentences.

Line 339 -- 341 -- sentence is confusing OIE was 85% whereas again using 58% to justify the discussion. Need to justify one percentage and use it throughout the manuscript particularly the discussion.

• We rewrote the paper and now stick to the OIE-recommendations throughout the whole paper.

Line 344 -- 346 -- Confusing sentence, needs fixing

• We rewrote the section and fixed all sentences.

Conclusion

Line 354 -- 356 -- Again, the authors do not present any data to be able to draw this conclusion on the handling of the vaccine. Either data needs to be added to the manuscript to justify the statement or remove the statement.

• We rewrote the section and removed the statement.

Reviewer \#2: 1. The meaning of this report on the evaluate if a vaccination interval of twelve weeks against Newcastle Disease under field conditions results in sufficient seroconversion to protect the flocks is significant, especially in Germany. By the author's work, some useful results gotten, like a vaccination interval of every twelve weeks with the live-vaccines tested is suitable for a vaccination protocol against Newcastle Disease.

• The authors thank the reviewer for his motivating comments.

2\. Vaccine can cause an enormous change of immunocytes,cytokines and antibody, cause a series of pathological and physiological change in the body.Therefore I suggest the author could discuss deeper about the effection about the vacction protocol by whether NDV infection rate were reduced which can be diagnosed by a number of different laboratory tests.For example,conclusion the change of B cell and T cell can reflected the pathogenesis. It may improve the diagnose. The main support data were only serological testing results I thought not enough.

• The authors thank the reviewer for his suggestions. Testing the changes of B and T cells is an interesting option that we bear in mind for further studies. Due to the value of each chicken to the breeder the collection of blood samples from living chickens was the only option available. Serological testing is also the standard choice of measurement of the vaccination success in commercial poultry flocks.

3\. If the author showed the data by graphs will be better than too many tables.

• We included one graph on the proportion of animals with protective titer in ELISA and HI test.

Reviewer \#3: The manuscript presents relevant data for poultry practitioners and producers in Germany.

I have just a few observations as follows;

• The authors thank the reviewer for his observations.

Since it has been stated that there is a current directive to vaccinate birds at 6 weeks, what necessitated that decision? Was is based on a study recommendation?

• The current directive is based on the current SPCs of available ND vaccines.

Is the protective antibody observed in this study significantly higher that what was observed following vaccination at 6 weeks?

• Unfortunately, we have no data regarding the antibody titer at 6 weeks after the vaccination in backyard poultry. We will keep this in mind for further studies.

Some of the flocks used in the study had less than 12 weeks since the last vaccination, would it not be better to give a range in days instead of weeks ?

• Since it is common in Germany to stick to weeks as interval for vaccination in poultry (backyard as well as commercial), we would prefer to give our recommendation in weeks to make it easier to understand for the reader.

Again, in order to appreciate the lower and upper limits, it would be preferable to use Mean and SE or SD.

• We specified the SD at the vaccination distance. In case of the number of the vaccinations the SD was not meaningful due to the extremely skewed distribution of the values to the right.

In-text citations are inconsistent e,g lines 248, 270,281, 286, 314, 322\....just to mention a few. Use standard journal citation and referencing style.

• We changed the citation to Vancouver-Style as outlined in the journal guidelines.

Reviewer \#4: \[General comments\]

This paper describes the analytical results on a survey for anti-NDV antibodies to discuss whether twelve-week interval of NDV vaccination is suffice to keep backyard poultry in Germany. The authors concluded that a vaccination interval of twelve weeks with the live-vaccines was suitable for vaccination protocol in backyard poultry.

The authors describes as the reason for this study is the direction from German Veterinarian Standing Committee of Immunization to re-vaccinate for NDV every six weeks, instead of every twelve weeks, which was regularly performed in Germany. However, in OIE manual issued in 2006, it is recommended to vaccinate every 8 weeks to keep HI titer of 2\^5. In this manuscript, the reason for the change to re-vaccination of six-week interval was not clearly described, thus, for the reviewer, the contents of this paper seemed to be of domestic importance.

• The authors thank the reviewer for his comments and suggestions. We rewrote some sections of the paper and clarify the reason for the change of the revaccination interval.

\[\[Comments for the contents\]\]

\[Sample information\]

Because the samples were taken from backyard chichen, the age, breed, aim and so on, would be variable. However, as the focus of this paper is to demonstrate the comparable efficacy to keep anti-NDV antibody titer by re-vaccination in twelve-week intervals, compared to those in six-week intervals.

In the S1 Raw data sheet, flock number, age in month, number of times of vaccination, and ELISA and HI for titers individuals are listed. In the text, the period from the last vaccination is described as 69-111days (approx. 10-16 weeks after LAST vaccination). However, I could not understand in which flock or even in which individuals followed six- or twelve-week interval revaccination, if the repeats of vaccination affects to the remaining titer. For example, chickens of 29 weeks old in different flock received 7 vaccinations, while 5 months chickens which are the major age group in this study encompassing 490 chicken out of total 810 chickens (60.5%) received 1 time vaccination. In OIE manual (2006), breeding hens are recommended to vaccinate twice by 14 or 18 weeks of age, for layer and broiler chickens, respectively (ND3.1-16FINAL(29Nov06) appendix 5). So, the more than half of chickens of 5 month received only single vaccination means that their vaccination schedule was different from the regular ones. The detailed schedule of vaccination of backyard chickens should be noticed for better understanding of the situdation.

• All flocks in this study were vaccinated in a twelve-week interval only. We added a table with different vaccination schemes including recommendations for basic immunization to clarify the actual situation in backyard poultry and to show the differences according to the recommendations for vaccination.

\[Value in tables\]

From the reference of van Boven et al (2008) demonstrating vaccinated chickens with HI titers of 2\^3 or more with strong protection, setting HI titer of 2\^4 as the minimum protective titer would be acceptable. However, in materials and methods, the authors described that HI titer of 2\^3 or less is considered as negative (according to OIE). I think it is unclear statement because HI titer of 2-1 to 2-3 is still clear in HI titer. OIE manual explained that as a protective titer, they recommended to determine HI titer of 2\^4 or 2\^3.

• We changed the wording from "negative" to "non-protective".

In table 2, the flock 1 including 30 samples in which includes 3 unmeasulable samples, 3 samples with HI titer of \<1, one of HI titer of 3. That means \"protective\" titer of 2\^4 or more would be 23 out of 27 available sample, equals to 85.2%, which is described as 90% protective. As similar, in flock 2, all of 30 samples showed HI titers of 1 or \<1. So, percentage of protective titer should be 0.0% (0/30), which is described as 10%. In materials and methods, the authors mentioned that they used R software. However, the authors should describe essential calculation formulars in the materials and methods so that the readers can easily understand.

• We reevaluated and corrected the numbers and also rewrote the section to clarify the way of calculation.

In table 2 \",\" and \".\" are mixed as period. \".\" should be used.

• This was amended as suggested.

As similar, protective HI titer in table 2 is 89%, while positive HI test (2\^4 or more?) in table 1 is 74.7%. My calculation from supplimented law data for proportion of HI titers 2\^4 or more is 75.3% (593/788: Total 810, IS=22, \<1=122, 1-3=73). No formular or legends (because they are tables) was indicated for the way of calculation.

• Also for the HI-titers we recalculated the numbers included in the table and also rewrote the section to clarify how we calculated the results.

\[Result interpretation\]

The title of this manuscript implies to demonstrate the decline of HI titer (or additionally ELISA titer for higher sensitivity) is calm (slow) enough to maintains the anti-NDV antibody titers at the protective levels. Results demonstrated high HI titers were still detected after 12 weeks (84 days). As described in the discussion, the factors such as the way of immunization, breeds, and others might affect to the (maintainance of) HI titers, description of the schedule of vaccination in addition to the number of repeated vaccination times would be required, as described above.

• As stated above, we included a table with the vaccination scheme used by the breeders whose chickens were tested in this study.

\[Correlation between ELISA titer and HI titer\]

Generally, neutralization titers are not always linearly correlated to whole antibody titers. In some our experiences, the protortion of neutralizing titer increased after repeated immunization. I think the protective value should be based on the HI titer not ELISA titer. In this section, more clear explanation about the aim of statistical comparison of these two values in order to evaluate the comparable efficacy of re-vaccination in twelve-week intervals.

• We rewrote the section about ELISA and HI titer in the discussion to show the differences of both tests. For this study we decided to combine the results of both tests to specify the protective titer.

\[breeds, ages, flock differences\]

Even no significant differences were demonstrated, the expectation or some examples in references which shows the difference between dofferent categories. Or if the authors put them for evaluation in case there might have some unexpected differences between breeds or others, the authors should not conclude that those differences might affect to the results (lines 315-322).

• We removed all statements that could argue against the results in this study.

\[Proofreading and other\]

Some grammatical mistakes and mistypes were found.　Order of the significant digits for the same category of values should be same.

• We correct the grammatical mistakes as well as the mistypes.
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